Cancer Research 09 AM Call for Abstracts SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaco, I.
Right arrow Articles by Blasco, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaco, I.
Right arrow Articles by Blasco, M. A.
[Cancer Research 64, 7271-7278, October 15, 2004]
© 2004 American Association for Cancer Research

Regular Articles

Role of Human Ku86 in Telomere Length Maintenance and Telomere Capping

Isabel Jaco, Purificación Muñoz and María A. Blasco

Molecular Oncology Program, Spanish National Cancer Center (CNIO), Madrid, Spain

The role of Ku86 at telomeres has been extensively studied in various organisms; however, a role for Ku86 at human telomeres was unknown because Ku86 deletion is lethal for human cells. Here, we used small interference RNA to decrease Ku86 protein levels in human cells. An ~50% reduction in the amount of Ku86 protein was achieved 72 hours after transfection with Ku86-specific small interference RNAs. This decrease in Ku86 levels resulted in a rapid loss of cell viability characterized by increased apoptosis and decreased mitotic index in the cell population. Importantly, Ku86 knockdown was concomitant with a significant loss of telomeric sequences and with increased chromosomal aberrations, including chromatid-type fusions involving telomeric sequences. These findings demonstrate a role for Ku86 in regulating telomere length and telomere capping in human cells, which, in turn, could impact on cancer and aging.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
B. L. Ruis, K. R. Fattah, and E. A. Hendrickson
The Catalytic Subunit of DNA-Dependent Protein Kinase Regulates Proliferation, Telomere Length, and Genomic Stability in Human Somatic Cells
Mol. Cell. Biol., October 15, 2008; 28(20): 6182 - 6195.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
S. Smith, S. Banerjee, R. Rilo, and K. Myung
Dynamic Regulation of Single-Stranded Telomeres in Saccharomyces cerevisiae
Genetics, February 1, 2008; 178(2): 693 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. L. Heacock, R. A. Idol, J. D. Friesner, A. B. Britt, and D. E. Shippen
Telomere dynamics and fusion of critically shortened telomeres in plants lacking DNA ligase IV
Nucleic Acids Res., October 8, 2007; 35(19): 6490 - 6500.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. R. Jones, D. A. Gewirtz, S. M. Yannone, S. Zhou, D. G. Schatz, K. Valerie, and L. F. Povirk
Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein
Mol. Cancer Ther., October 1, 2005; 4(10): 1541 - 1547.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.